METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): DIAGNOSTIC CRITERIA AND EMERGING PHARMACOTHERAPY . ITFTTDM. 2026;4(9):129-31. Accessed October 8, 2026. https://universalpublishings.com/index.php/itfttdm/article/view/20686